{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:48:48Z","timestamp":1759340928386},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00296-014-3069-0","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T08:20:56Z","timestamp":1403166056000},"page":"167-170","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Higher level of IL-6 in Jaccoud\u2019s arthropathy secondary to systemic lupus erythematosus: a perspective for its treatment?"],"prefix":"10.1007","volume":"35","author":[{"given":"Ajax Merc\u00eas","family":"Atta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana P.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taciana P. S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza B.","family":"Sousa Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mittermayer B.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"3069_CR1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.berh.2011.10.018","volume":"25","author":"MB Santiago","year":"2011","unstructured":"Santiago MB (2011) Miscellaneous non-inflammatory musculoskeletal conditions. Jaccoud\u2019s arthropathy. Best Pract Res Clin Rheumatol 25:715\u2013725","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3069_CR2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3069_CR3","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00296-012-2526-x","volume":"33","author":"MB Santiago","year":"2013","unstructured":"Santiago MB (2013) Jaccoud\u2019s arthropathy: proper classification criteria and treatment are still needed. Rheumatol Int 33(11):2953\u20132954","journal-title":"Rheumatol Int"},{"key":"3069_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0961203310385163","volume":"20","author":"Z Touma","year":"2011","unstructured":"Touma Z, Urowitz MB, Ibanez D, Gladman DD (2011) SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus 20:67\u201370","journal-title":"Lupus"},{"key":"3069_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181632d18","volume":"87","author":"MB Santiago","year":"2008","unstructured":"Santiago MB, Galvao V (2008) Jaccoud arthropathy in systemic lupus erythematosus: analysis of clinical characteristics and review of the literature. Medicine 87:37\u201344","journal-title":"Medicine"},{"key":"3069_CR6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ard.2004.026559","volume":"64","author":"MC Zweers","year":"2005","unstructured":"Zweers MC, Kucharekova M, Schalkwijk J (2005) Tenascin-X: a candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome? Ann Rheum Dis 64:504\u2013505","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"3069_CR7","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","volume":"4","author":"T Naka","year":"2002","unstructured":"Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4(Suppl 3):S233\u2013S242","journal-title":"Arthritis Res"},{"key":"3069_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","volume":"147","author":"M Linker-Israeli","year":"1991","unstructured":"Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. J Immunol 147:117\u2013123","journal-title":"J Immunol"},{"key":"3069_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2249.1992.tb05840.x","volume":"90","author":"PE Spronk","year":"1992","unstructured":"Spronk PE, ter Borg EJ, Limburg PC, Kallenberg CG (1992) Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 90:106\u2013110","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"3069_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0961203310392432","volume":"20","author":"GO Eilertsen","year":"2011","unstructured":"Eilertsen GO, Nikolaisen C, Becker-Merok A, Nossent JC (2011) Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus. Lupus 20(6):607\u2013613","journal-title":"Lupus"},{"key":"3069_CR11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1385\/IR:27:2-3:529","volume":"27","author":"KE Sullivan","year":"2003","unstructured":"Sullivan KE (2003) Regulation of inflammation. Immunol Res 27:529\u2013538","journal-title":"Immunol Res"},{"key":"3069_CR12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.27221","volume":"62","author":"GG Illei","year":"2010","unstructured":"Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K, Fleisher T, Balow JE, Lipsky PE (2010) Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum 62:542\u2013552","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3069-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3069-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T11:33:30Z","timestamp":1689334410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3069-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3069"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3069-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,18]]}}}